Myocardial Infarction
Products Related to Myocardial Infarction(61)
- GC49509Glycyl-L-Glutamine (hydrate)CAS: 172669-64-6Purity: >97.50%
A dipeptide fragment of β-endorphin
- GC52019Norpropranolol (hydrochloride)CAS: 62618-09-1Purity: >98.00%
An active metabolite of propranolol
- GC52180WAY-169916CAS: 669764-18-5Purity: >98.00%
WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity.
- GC52193EptifibatideCAS: 188627-80-7Purity: >98.00%
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.
- GC52221EleclazineCAS: 1443211-72-0Purity: >98.00%
Eleclazine is a novel, highly selective inhibitor of the cardiac late sodium current, with an IC 50 value of <1μM.
- GC52342P4pal10 (trifluoroacetate salt)Purity: >98.00%
A PAR4 and FPR2 antagonist and an FFAR2 agonist
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49509 | Glycyl-L-Glutamine (hydrate) | 172669-64-6 | >97.50% | |
A dipeptide fragment of β-endorphin | ||||
| GC49511 | Nicorandil N-oxide | 107833-98-7 | >98.00% | |
A metabolite of nicorandil | ||||
| GC49671 | 2,3-Oxidosqualene | 7200-26-2 | >90.00% | |
An intermediate in the biosynthesis of sterols | ||||
| GC49842 | Digoxigenin Bisdigitoxoside | 5297-05-2 | >98.00% | |
A Na + /K + -ATPase inhibitor | ||||
| GC52019 | Norpropranolol (hydrochloride) | 62618-09-1 | >98.00% | |
An active metabolite of propranolol | ||||
| GC52035 | Esmolol Acid (hydrochloride) | 83356-60-9 | >98.00% | |
An active metabolite of esmolol | ||||
| GC52125 | T-1095 | 209746-59-8 | >98.00% | |
T-1095 is a selective and orally active Na+-glucose cotransporter (SGLT) inhibitor with IC50s of 22.8 ?M and 2.3 ?M for human SGLT1 and SGLT2, respectively. | ||||
| GC52180 | WAY-169916 | 669764-18-5 | >98.00% | |
WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity. | ||||
| GC52193 | Eptifibatide | 188627-80-7 | >98.00% | |
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity. | ||||
| GC52221 | Eleclazine | 1443211-72-0 | >98.00% | |
Eleclazine is a novel, highly selective inhibitor of the cardiac late sodium current, with an IC 50 value of <1μM. | ||||
| GC52342 | P4pal10 (trifluoroacetate salt) | - | >98.00% | |
A PAR4 and FPR2 antagonist and an FFAR2 agonist | ||||
| GC52460 | tcY-NH2 (trifluoroacetate salt) | - | >98.00% | |
A peptide antagonist of PAR4 | ||||
| GC91100 | UCL-TRO-1938 | 2919575-27-0 | >98.00% | |
An allosteric PI3Kα activator | ||||